Dimensional Fund Advisors LP Opiant Pharmaceuticals, Inc. Transaction History

Dimensional Fund Advisors LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$9.38 - $20.29 $115,214 - $249,222	-12,283 Reduced 10.92%	100,209 $2.03 Million
Q3 2022 Nov 10, 2022	SELL	$9.52 - $13.48 $140,896 - $199,504	-14,800 Reduced 11.63%	112,492 $1.21 Million
Q2 2022 Aug 12, 2022	BUY	$10.12 - $23.32 $208,573 - $480,625	20,610 Added 19.32%	127,292 $1.53 Million
Q1 2022 May 13, 2022	BUY	$19.54 - $33.59 $782,205 - $1.34 Million	40,031 Added 60.06%	106,682 $2.29 Million
Q4 2021 Feb 09, 2022	BUY	$22.51 - $36.79 $507,442 - $829,356	22,543 Added 51.11%	66,651 $2.24 Million
Q3 2021 Nov 12, 2021	BUY	$13.28 - $25.79 $296,754 - $576,303	22,346 Added 102.68%	44,108 $1.14 Million
Q2 2021 Aug 12, 2021	SELL	$10.5 - $14.19 $724 - $979	-69 Reduced 0.32%	21,762 $301,000
Q1 2021 May 14, 2021	BUY	$8.2 - $14.49 $18,474 - $32,645	2,253 Added 11.51%	21,831 $232,000
Q4 2020 Feb 25, 2021	BUY	$6.87 - $8.88 $134,500 - $173,852	19,578 New	19,578 $158,000

300

Ticker OPNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 5,164,150
Description
Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overd...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.